NCT03526627 is a clinical trial in Advanced Heart Failure, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT03526627?

NCT03526627 is sponsored by National Taiwan University Hospital.

What condition does NCT03526627 study?

NCT03526627 studies Advanced Heart Failure.

Is NCT03526627 still recruiting?

NCT03526627 is currently status unknown. Last updated 22 June 2020.

Last reviewed 2020-06-22 · How we verify

NCT03526627

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Advanced Care Management in Patients With Advanced Heart Failure

Status unknown Last updated 22 June 2020

What this trial tests

trial in Advanced Heart Failure in 227 participants. Status unknown.

Timeline

4 January 2018

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	National Taiwan University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	227
Start date	4 January 2018
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Taiwan

Conditions studied

Advanced Heart Failure — all drugs for Advanced Heart Failure →

Sponsor

National Taiwan University Hospital

Who can join

20 and older, any sex, with Advanced Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the trajectory of advanced management care in patients with heart failure over a period of 9 months, then comparing the medical treatment accepted by patients after 2 years later and compliance with the preferences of patients and their families.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Advanced Heart Failure

Currently open trials in the same condition.

NCT07497308 — GDF-15 and Early Outcomes After LVAD Implantation · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03526627 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 22 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03526627.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing